15 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
. Some of the raw materials that we anticipate will be required in our manufacturing process are derived from biologic sources. Such raw materials
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
candidates on schedule and could harm our results of operations and cause reputational damage. Some of the raw materials that we anticipate will be required … in our manufacturing process are derived from biologic sources. Such raw materials are difficult to procure and may be subject to contamination
S-1/A
n36ivu
13 Oct 22
IPO registration (amended)
10:51am
S-1
34qotipfea0qlrr2dbm5
23 Sep 22
IPO registration
4:12pm
DRS/A
femuq 41764gx0i
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
v2m4ifbluv5d
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
1f20woyz665v 7zq4bly
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
gkjzeykb
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
p8yywlhrdnlfrv6
7 Mar 22
Draft registration statement (amended)
12:00am
DRSLTR
iz129
4 Feb 22
Correspondence regarding draft registration statement
12:00am
DRS/A
2qy6m yb660w
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
27ho vobxlzo5xkee
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next